Literature DB >> 23303884

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.

An-Wen Chan1, Jennifer M Tetzlaff, Peter C Gøtzsche, Douglas G Altman, Howard Mann, Jesse A Berlin, Kay Dickersin, Asbjørn Hróbjartsson, Kenneth F Schulz, Wendy R Parulekar, Karmela Krleza-Jeric, Andreas Laupacis, David Moher.   

Abstract

High quality protocols facilitate proper conduct, reporting, and external review of clinical trials. However, the completeness of trial protocols is often inadequate. To help improve the content and quality of protocols, an international group of stakeholders developed the SPIRIT 2013 Statement (Standard Protocol Items: Recommendations for Interventional Trials). The SPIRIT Statement provides guidance in the form of a checklist of recommended items to include in a clinical trial protocol. This SPIRIT 2013 Explanation and Elaboration paper provides important information to promote full understanding of the checklist recommendations. For each checklist item, we provide a rationale and detailed description; a model example from an actual protocol; and relevant references supporting its importance. We strongly recommend that this explanatory paper be used in conjunction with the SPIRIT Statement. A website of resources is also available (www.spirit-statement.org). The SPIRIT 2013 Explanation and Elaboration paper, together with the Statement, should help with the drafting of trial protocols. Complete documentation of key trial elements can facilitate transparency and protocol review for the benefit of all stakeholders.

Mesh:

Year:  2013        PMID: 23303884      PMCID: PMC3541470          DOI: 10.1136/bmj.e7586

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  353 in total

1.  Clinical trials should begin and end with systematic reviews of relevant evidence: 12 years and waiting.

Authors:  Mike Clarke; Sally Hopewell; Iain Chalmers
Journal:  Lancet       Date:  2010-07-03       Impact factor: 79.321

2.  Testing for the presence of positive-outcome bias in peer review: a randomized controlled trial.

Authors:  Gwendolyn B Emerson; Winston J Warme; Fredric M Wolf; James D Heckman; Richard A Brand; Seth S Leopold
Journal:  Arch Intern Med       Date:  2010-11-22

3.  Randomized controlled trials of aprotinin in cardiac surgery: could clinical equipoise have stopped the bleeding?

Authors:  Dean Fergusson; Kathleen Cranley Glass; Brian Hutton; Stan Shapiro
Journal:  Clin Trials       Date:  2005       Impact factor: 2.486

4.  European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications.

Authors:  Adam Jacobs; Elizabeth Wager
Journal:  Curr Med Res Opin       Date:  2005-02       Impact factor: 2.580

5.  Quality of reporting of noninferiority and equivalence randomized trials.

Authors:  Anne Le Henanff; Bruno Giraudeau; Gabriel Baron; Philippe Ravaud
Journal:  JAMA       Date:  2006-03-08       Impact factor: 56.272

6.  Blinding during data analysis and writing of manuscripts.

Authors:  P C Gøtzsche
Journal:  Control Clin Trials       Date:  1996-08

7.  [Readability of informed consent forms for subjects participating in biomedical research: updating is required].

Authors:  A Paris; J-L Cracowski; N Ravanel; C Cornu; F Gueyffier; B Deygas; K Guillot; J-L Bosson; M Hommel
Journal:  Presse Med       Date:  2005-01-15       Impact factor: 1.228

8.  Quality of controlled clinical trials on glaucoma and intraocular high pressure.

Authors:  Javier Llorca; Fernando Martínez-Sanz; Dolores Prieto-Salceda; Concepción Fariñas-Alvarez; M Verónica Chinchón; Dolores Quinones; Miguel Delgado-Rodríguez
Journal:  J Glaucoma       Date:  2005-06       Impact factor: 2.503

9.  The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed.

Authors:  Sally Hopewell; Susan Dutton; Ly-Mee Yu; An-Wen Chan; Douglas G Altman
Journal:  BMJ       Date:  2010-03-23

10.  Why we need easy access to all data from all clinical trials and how to accomplish it.

Authors:  Peter C Gøtzsche
Journal:  Trials       Date:  2011-11-23       Impact factor: 2.279

View more
  1660 in total

Review 1.  The evolution in registration of clinical trials: a chronicle of the historical calls and current initiatives promoting transparency.

Authors:  Claudia Pansieri; Chiara Pandolfini; Maurizio Bonati
Journal:  Eur J Clin Pharmacol       Date:  2015-08-05       Impact factor: 2.953

2.  Acute coronary syndrome quality improvement in Kerala (ACS QUIK): Rationale and design for a cluster-randomized stepped-wedge trial.

Authors:  Mark D Huffman; Padinhare Purayil Mohanan; Raji Devarajan; Abigail S Baldridge; Dimple Kondal; Lihui Zhao; Mumtaj Ali; Donald M Lloyd-Jones; Dorairaj Prabhakaran
Journal:  Am Heart J       Date:  2016-12-21       Impact factor: 4.749

3.  Author's reply to Shrier: "Publication bias, with a focus on psychiatry: causes and solutions".

Authors:  Erick H Turner
Journal:  CNS Drugs       Date:  2013-09       Impact factor: 5.749

Review 4.  Evidence for compliance with long-term medication: a systematic review of randomised controlled trials.

Authors:  Michelle A King; Rebecca L Pryce
Journal:  Int J Clin Pharm       Date:  2013-11-30

5.  The Ontology of Clinical Research (OCRe): an informatics foundation for the science of clinical research.

Authors:  Ida Sim; Samson W Tu; Simona Carini; Harold P Lehmann; Brad H Pollock; Mor Peleg; Knut M Wittkowski
Journal:  J Biomed Inform       Date:  2013-11-13       Impact factor: 6.317

6.  Intensive Balance Training for Adults With Incomplete Spinal Cord Injuries: Protocol for an Assessor-Blinded Randomized Clinical Trial.

Authors:  Janelle Unger; Katherine Chan; Carol Y Scovil; B Catharine Craven; Avril Mansfield; Kei Masani; Kristin E Musselman
Journal:  Phys Ther       Date:  2019-04-01

7.  Personalized upper limb training combined with anodal-tDCS for sensorimotor recovery in spastic hemiparesis: study protocol for a randomized controlled trial.

Authors:  Mindy F Levin; Melanie C Baniña; Silvi Frenkel-Toledo; Sigal Berman; Nachum Soroker; John M Solomon; Dario G Liebermann
Journal:  Trials       Date:  2018-01-04       Impact factor: 2.279

8.  Design of non-inferiority randomized trials using the difference in restricted mean survival times.

Authors:  Isabelle R Weir; Ludovic Trinquart
Journal:  Clin Trials       Date:  2018-08-03       Impact factor: 2.486

9.  Surgical portosystemic shunts versus devascularisation procedures for prevention of variceal rebleeding in people with hepatosplenic schistosomiasis.

Authors:  Chikwendu J Ede; Dimitrinka Nikolova; Martin Brand
Journal:  Cochrane Database Syst Rev       Date:  2018-08-03

10.  Methodology guideline for clinical studies investigating traditional Chinese medicine and integrative medicine: executive summary.

Authors:  Jian-Ping Liu; Ke-Ji Chen
Journal:  Complement Ther Med       Date:  2015-10       Impact factor: 2.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.